| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endothelial Cells | 14 | 2024 | 527 | 3.290 |
Why?
|
| Endothelium, Vascular | 11 | 2021 | 514 | 2.910 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-1 | 6 | 2021 | 31 | 2.070 |
Why?
|
| Carrier Proteins | 7 | 2021 | 1018 | 1.630 |
Why?
|
| Receptors, LDL | 3 | 2017 | 88 | 1.440 |
Why?
|
| Signal Transduction | 18 | 2024 | 4489 | 1.260 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2017 | 467 | 1.200 |
Why?
|
| Hypoxia-Inducible Factor-Proline Dioxygenases | 5 | 2021 | 23 | 1.140 |
Why?
|
| Acute Lung Injury | 2 | 2018 | 62 | 1.130 |
Why?
|
| Neovascularization, Physiologic | 6 | 2014 | 211 | 1.120 |
Why?
|
| Cell Movement | 9 | 2018 | 831 | 0.910 |
Why?
|
| Chemokine CXCL12 | 2 | 2014 | 33 | 0.790 |
Why?
|
| Hyperglycemia | 2 | 2021 | 221 | 0.760 |
Why?
|
| Osteocalcin | 1 | 2021 | 40 | 0.760 |
Why?
|
| Capillary Permeability | 2 | 2018 | 78 | 0.750 |
Why?
|
| Procollagen-Proline Dioxygenase | 5 | 2021 | 35 | 0.700 |
Why?
|
| Mice, Knockout | 13 | 2024 | 3718 | 0.660 |
Why?
|
| HEK293 Cells | 5 | 2021 | 740 | 0.620 |
Why?
|
| Insulin Resistance | 2 | 2021 | 639 | 0.610 |
Why?
|
| Vasculitis | 1 | 2018 | 49 | 0.610 |
Why?
|
| Bone Morphogenetic Protein 4 | 3 | 2012 | 37 | 0.590 |
Why?
|
| Cells, Cultured | 14 | 2024 | 3042 | 0.590 |
Why?
|
| Glucose | 2 | 2021 | 872 | 0.580 |
Why?
|
| Endocytosis | 4 | 2017 | 124 | 0.570 |
Why?
|
| Endotoxins | 1 | 2017 | 47 | 0.560 |
Why?
|
| Lipopolysaccharides | 1 | 2018 | 290 | 0.550 |
Why?
|
| Metabolic Diseases | 1 | 2018 | 130 | 0.550 |
Why?
|
| PPAR gamma | 1 | 2017 | 91 | 0.550 |
Why?
|
| Animals | 32 | 2024 | 33767 | 0.520 |
Why?
|
| Retinal Neovascularization | 1 | 2015 | 14 | 0.520 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2015 | 56 | 0.500 |
Why?
|
| Retinal Vessels | 1 | 2015 | 74 | 0.490 |
Why?
|
| Inflammation Mediators | 2 | 2017 | 233 | 0.490 |
Why?
|
| Reactive Oxygen Species | 2 | 2015 | 477 | 0.470 |
Why?
|
| Cardiovascular System | 1 | 2015 | 99 | 0.460 |
Why?
|
| Homeostasis | 1 | 2018 | 682 | 0.450 |
Why?
|
| NADPH Oxidases | 1 | 2014 | 114 | 0.450 |
Why?
|
| Mitogen-Activated Protein Kinase 10 | 2 | 2014 | 6 | 0.440 |
Why?
|
| Mitogen-Activated Protein Kinase Phosphatases | 2 | 2014 | 15 | 0.440 |
Why?
|
| Dual-Specificity Phosphatases | 2 | 2014 | 22 | 0.440 |
Why?
|
| Pneumonia | 1 | 2017 | 324 | 0.440 |
Why?
|
| Cell Proliferation | 4 | 2019 | 2307 | 0.430 |
Why?
|
| Energy Metabolism | 1 | 2018 | 770 | 0.430 |
Why?
|
| Bone Morphogenetic Protein Receptors | 2 | 2014 | 10 | 0.420 |
Why?
|
| Myocytes, Cardiac | 5 | 2022 | 616 | 0.390 |
Why?
|
| Mice | 20 | 2024 | 17512 | 0.390 |
Why?
|
| Mice, Inbred C57BL | 8 | 2024 | 4354 | 0.390 |
Why?
|
| Bone Morphogenetic Proteins | 2 | 2014 | 124 | 0.390 |
Why?
|
| Transfection | 5 | 2017 | 1068 | 0.380 |
Why?
|
| Zebrafish Proteins | 1 | 2012 | 105 | 0.380 |
Why?
|
| Inflammation | 3 | 2023 | 1401 | 0.370 |
Why?
|
| Cell Adhesion Molecules | 1 | 2012 | 224 | 0.370 |
Why?
|
| RNA Interference | 4 | 2017 | 496 | 0.350 |
Why?
|
| Aortic Diseases | 1 | 2012 | 197 | 0.340 |
Why?
|
| Apoptosis | 4 | 2017 | 1781 | 0.340 |
Why?
|
| Lung | 1 | 2017 | 1460 | 0.330 |
Why?
|
| Muscle, Skeletal | 1 | 2015 | 937 | 0.320 |
Why?
|
| Glucose Tolerance Test | 2 | 2021 | 207 | 0.310 |
Why?
|
| Proto-Oncogene Proteins c-akt | 4 | 2024 | 488 | 0.310 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 2 | 2005 | 6 | 0.310 |
Why?
|
| Pseudopodia | 1 | 2007 | 6 | 0.300 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2009 | 220 | 0.300 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2007 | 413 | 0.300 |
Why?
|
| Myosins | 1 | 2007 | 46 | 0.300 |
Why?
|
| Neovascularization, Pathologic | 2 | 2014 | 240 | 0.290 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2007 | 35 | 0.290 |
Why?
|
| Cattle | 4 | 2014 | 558 | 0.290 |
Why?
|
| Gene Expression Regulation | 3 | 2021 | 2526 | 0.280 |
Why?
|
| Membrane Proteins | 1 | 2014 | 1528 | 0.270 |
Why?
|
| Atherosclerosis | 2 | 2014 | 831 | 0.260 |
Why?
|
| Aorta | 2 | 2014 | 542 | 0.250 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 4 | 2015 | 98 | 0.240 |
Why?
|
| Phenotype | 4 | 2017 | 4223 | 0.240 |
Why?
|
| Smad5 Protein | 1 | 2024 | 22 | 0.230 |
Why?
|
| Smad1 Protein | 1 | 2024 | 22 | 0.230 |
Why?
|
| Disease Models, Animal | 6 | 2024 | 4275 | 0.230 |
Why?
|
| Stress, Mechanical | 4 | 2024 | 170 | 0.230 |
Why?
|
| Vascular Remodeling | 1 | 2024 | 41 | 0.230 |
Why?
|
| Oxidation-Reduction | 2 | 2015 | 444 | 0.220 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2024 | 110 | 0.220 |
Why?
|
| Carnitine O-Acetyltransferase | 1 | 2023 | 2 | 0.220 |
Why?
|
| Time Factors | 4 | 2017 | 6218 | 0.210 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2003 | 206 | 0.210 |
Why?
|
| Smegmamorpha | 1 | 2022 | 1 | 0.200 |
Why?
|
| Nitrates | 1 | 2002 | 27 | 0.200 |
Why?
|
| Fatty Acids | 2 | 2022 | 338 | 0.200 |
Why?
|
| Voltage-Dependent Anion Channel 1 | 1 | 2021 | 23 | 0.190 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2021 | 25 | 0.190 |
Why?
|
| Mice, Transgenic | 5 | 2019 | 2391 | 0.190 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2021 | 78 | 0.190 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2021 | 95 | 0.190 |
Why?
|
| Humans | 19 | 2024 | 123036 | 0.190 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2021 | 91 | 0.190 |
Why?
|
| Receptors, Leptin | 1 | 2021 | 42 | 0.180 |
Why?
|
| Hyperinsulinism | 1 | 2021 | 68 | 0.180 |
Why?
|
| Organ Specificity | 2 | 2017 | 423 | 0.180 |
Why?
|
| Osteoblasts | 1 | 2021 | 149 | 0.180 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 2 | 2012 | 31 | 0.180 |
Why?
|
| Glucose Intolerance | 1 | 2021 | 75 | 0.180 |
Why?
|
| Genes, Reporter | 1 | 2021 | 384 | 0.170 |
Why?
|
| Green Fluorescent Proteins | 1 | 2021 | 394 | 0.170 |
Why?
|
| Heart | 2 | 2015 | 723 | 0.170 |
Why?
|
| Oxygen | 2 | 2015 | 547 | 0.170 |
Why?
|
| Insulin-Secreting Cells | 1 | 2021 | 147 | 0.170 |
Why?
|
| Genotype | 3 | 2015 | 2535 | 0.170 |
Why?
|
| Diet, High-Fat | 2 | 2021 | 208 | 0.170 |
Why?
|
| Recombinant Proteins | 3 | 2012 | 1386 | 0.170 |
Why?
|
| Protein Binding | 3 | 2021 | 1741 | 0.160 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2015 | 239 | 0.160 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2021 | 279 | 0.160 |
Why?
|
| Hypoxia | 3 | 2015 | 247 | 0.160 |
Why?
|
| Cholesterol | 2 | 2023 | 525 | 0.160 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2018 | 27 | 0.160 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 2 | 2024 | 87 | 0.150 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2018 | 80 | 0.150 |
Why?
|
| Heart Failure | 2 | 2023 | 2127 | 0.150 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2018 | 130 | 0.150 |
Why?
|
| Transcription, Genetic | 3 | 2017 | 1695 | 0.150 |
Why?
|
| Cell Adhesion | 1 | 2018 | 318 | 0.150 |
Why?
|
| Cadherins | 1 | 2018 | 164 | 0.150 |
Why?
|
| Nuclear Factor 45 Protein | 1 | 2017 | 2 | 0.150 |
Why?
|
| Leukocytes | 1 | 2018 | 207 | 0.140 |
Why?
|
| NFATC Transcription Factors | 1 | 2017 | 42 | 0.140 |
Why?
|
| CD36 Antigens | 1 | 2017 | 35 | 0.140 |
Why?
|
| Phosphorylation | 2 | 2015 | 1608 | 0.140 |
Why?
|
| MAP Kinase Signaling System | 1 | 2018 | 315 | 0.140 |
Why?
|
| Adipokines | 1 | 2017 | 58 | 0.140 |
Why?
|
| Blood Glucose | 1 | 2021 | 1119 | 0.140 |
Why?
|
| Thiazolidinediones | 1 | 2017 | 79 | 0.130 |
Why?
|
| Insulin | 1 | 2021 | 1200 | 0.130 |
Why?
|
| Gene Knockdown Techniques | 2 | 2014 | 350 | 0.130 |
Why?
|
| RNA, Messenger | 3 | 2017 | 2809 | 0.130 |
Why?
|
| Physical Conditioning, Animal | 1 | 2017 | 91 | 0.130 |
Why?
|
| Haploinsufficiency | 1 | 2017 | 247 | 0.130 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2015 | 21 | 0.130 |
Why?
|
| Cell Hypoxia | 1 | 2015 | 94 | 0.130 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2015 | 49 | 0.130 |
Why?
|
| Oxidative Stress | 3 | 2015 | 795 | 0.130 |
Why?
|
| Mixed Function Oxygenases | 1 | 2015 | 32 | 0.130 |
Why?
|
| Retinoblastoma Protein | 1 | 2015 | 77 | 0.130 |
Why?
|
| Male | 10 | 2024 | 60069 | 0.130 |
Why?
|
| Myocardial Ischemia | 2 | 2015 | 332 | 0.130 |
Why?
|
| Heart Valves | 1 | 2015 | 51 | 0.120 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2015 | 84 | 0.120 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2015 | 58 | 0.120 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 1 | 1 | 2015 | 2 | 0.120 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2011 | 665 | 0.120 |
Why?
|
| Transcription Factors | 1 | 2005 | 2585 | 0.120 |
Why?
|
| SOX9 Transcription Factor | 1 | 2015 | 79 | 0.120 |
Why?
|
| Isoindoles | 1 | 2014 | 3 | 0.120 |
Why?
|
| Organoselenium Compounds | 1 | 2014 | 5 | 0.120 |
Why?
|
| Neointima | 1 | 2015 | 43 | 0.120 |
Why?
|
| Azoles | 1 | 2014 | 9 | 0.120 |
Why?
|
| Weight Gain | 1 | 2017 | 401 | 0.110 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2015 | 216 | 0.110 |
Why?
|
| Cell Line | 3 | 2015 | 2771 | 0.110 |
Why?
|
| Acetylcysteine | 1 | 2014 | 73 | 0.110 |
Why?
|
| Calcium-Binding Proteins | 1 | 2015 | 327 | 0.110 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2015 | 160 | 0.110 |
Why?
|
| Lipids | 1 | 2017 | 515 | 0.110 |
Why?
|
| Isoenzymes | 1 | 2014 | 223 | 0.110 |
Why?
|
| Models, Anatomic | 1 | 2014 | 98 | 0.110 |
Why?
|
| RNA, Small Interfering | 2 | 2012 | 664 | 0.110 |
Why?
|
| Models, Cardiovascular | 1 | 2014 | 180 | 0.110 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2015 | 144 | 0.110 |
Why?
|
| Myocardium | 2 | 2015 | 985 | 0.110 |
Why?
|
| Enzyme Activation | 2 | 2005 | 617 | 0.110 |
Why?
|
| Cell Cycle | 1 | 2015 | 614 | 0.110 |
Why?
|
| DNA Damage | 2 | 2015 | 505 | 0.100 |
Why?
|
| Vascular Diseases | 1 | 2014 | 163 | 0.100 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2012 | 63 | 0.100 |
Why?
|
| Dioxygenases | 1 | 2012 | 46 | 0.100 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2012 | 133 | 0.100 |
Why?
|
| Rats | 5 | 2015 | 3653 | 0.100 |
Why?
|
| Myocardial Infarction | 1 | 2019 | 1000 | 0.100 |
Why?
|
| Antioxidants | 1 | 2014 | 338 | 0.100 |
Why?
|
| Vascular Calcification | 1 | 2012 | 53 | 0.100 |
Why?
|
| Apolipoproteins E | 1 | 2012 | 189 | 0.100 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2011 | 22 | 0.090 |
Why?
|
| Cytokines | 1 | 2017 | 1282 | 0.090 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2012 | 211 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2021 | 1230 | 0.090 |
Why?
|
| Interleukin-11 | 1 | 2010 | 7 | 0.090 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2014 | 996 | 0.090 |
Why?
|
| Hindlimb | 1 | 2010 | 75 | 0.090 |
Why?
|
| Coronary Vessels | 1 | 2014 | 526 | 0.090 |
Why?
|
| Femoral Artery | 1 | 2010 | 190 | 0.080 |
Why?
|
| Zebrafish | 1 | 2012 | 386 | 0.080 |
Why?
|
| Cell Differentiation | 2 | 2007 | 1909 | 0.080 |
Why?
|
| Models, Biological | 1 | 2014 | 1444 | 0.080 |
Why?
|
| Hydroxylation | 2 | 2021 | 45 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2015 | 1213 | 0.080 |
Why?
|
| Bone Morphogenetic Protein 6 | 1 | 2007 | 10 | 0.080 |
Why?
|
| Smad Proteins | 1 | 2007 | 43 | 0.070 |
Why?
|
| Ischemia | 1 | 2010 | 344 | 0.070 |
Why?
|
| Cell Polarity | 1 | 2007 | 124 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 3077 | 0.070 |
Why?
|
| Stem Cells | 2 | 2014 | 700 | 0.070 |
Why?
|
| Animals, Newborn | 2 | 2022 | 991 | 0.060 |
Why?
|
| Wnt Proteins | 1 | 2006 | 196 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2005 | 94 | 0.060 |
Why?
|
| 3',5'-Cyclic-GMP Phosphodiesterases | 1 | 2004 | 38 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2005 | 111 | 0.060 |
Why?
|
| Cyclic GMP | 1 | 2004 | 92 | 0.060 |
Why?
|
| Ubiquitin | 1 | 2005 | 141 | 0.060 |
Why?
|
| bcl-Associated Death Protein | 1 | 2003 | 4 | 0.060 |
Why?
|
| MAP Kinase Kinase 5 | 1 | 2003 | 3 | 0.060 |
Why?
|
| Culture Media, Serum-Free | 1 | 2003 | 22 | 0.060 |
Why?
|
| Cycloheximide | 1 | 2003 | 43 | 0.060 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2024 | 60 | 0.060 |
Why?
|
| Embryo, Mammalian | 1 | 2006 | 452 | 0.060 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2003 | 37 | 0.060 |
Why?
|
| Angiotensin II | 1 | 2004 | 161 | 0.060 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2003 | 123 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2003 | 83 | 0.050 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2004 | 256 | 0.050 |
Why?
|
| Caspase 3 | 1 | 2003 | 131 | 0.050 |
Why?
|
| Nucleotidyltransferases | 1 | 2023 | 45 | 0.050 |
Why?
|
| United States | 1 | 2018 | 10639 | 0.050 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2003 | 160 | 0.050 |
Why?
|
| Caspases | 1 | 2003 | 158 | 0.050 |
Why?
|
| Interferon Type I | 1 | 2023 | 107 | 0.050 |
Why?
|
| Tropoelastin | 1 | 2002 | 1 | 0.050 |
Why?
|
| Stress, Physiological | 2 | 2015 | 258 | 0.050 |
Why?
|
| Globins | 1 | 2002 | 35 | 0.050 |
Why?
|
| Gelsolin | 1 | 2002 | 13 | 0.050 |
Why?
|
| Nitroglycerin | 1 | 2002 | 23 | 0.050 |
Why?
|
| Blotting, Northern | 1 | 2002 | 258 | 0.050 |
Why?
|
| Respiration | 1 | 2022 | 122 | 0.050 |
Why?
|
| GTP-Binding Proteins | 1 | 2002 | 171 | 0.050 |
Why?
|
| Drug Resistance | 1 | 2002 | 255 | 0.050 |
Why?
|
| Gene Library | 1 | 2002 | 220 | 0.050 |
Why?
|
| Lipid Peroxidation | 1 | 2021 | 82 | 0.050 |
Why?
|
| Cell Survival | 1 | 2003 | 808 | 0.050 |
Why?
|
| Carnitine | 1 | 2021 | 78 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2021 | 316 | 0.050 |
Why?
|
| Immunity, Innate | 1 | 2023 | 372 | 0.040 |
Why?
|
| Lysosomes | 2 | 2015 | 232 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2003 | 548 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2006 | 1680 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2010 | 66 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2002 | 1584 | 0.040 |
Why?
|
| Mitochondria | 1 | 2021 | 677 | 0.030 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2019 | 359 | 0.030 |
Why?
|
| Thyroid Hormone Receptors alpha | 1 | 2015 | 14 | 0.030 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 1 | 2015 | 37 | 0.030 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2015 | 19 | 0.030 |
Why?
|
| Enzyme Induction | 1 | 2015 | 103 | 0.030 |
Why?
|
| Carotid Artery Injuries | 1 | 2015 | 39 | 0.030 |
Why?
|
| Protein Interaction Mapping | 1 | 2015 | 84 | 0.030 |
Why?
|
| Shear Strength | 1 | 2014 | 17 | 0.030 |
Why?
|
| Protein Stability | 1 | 2015 | 164 | 0.030 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2015 | 168 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 2015 | 247 | 0.030 |
Why?
|
| Proteolysis | 1 | 2015 | 165 | 0.030 |
Why?
|
| Myocardial Contraction | 1 | 2015 | 260 | 0.030 |
Why?
|
| Calcium Signaling | 1 | 2015 | 241 | 0.030 |
Why?
|
| Doxorubicin | 1 | 2015 | 299 | 0.030 |
Why?
|
| Cell Division | 1 | 2015 | 780 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2014 | 408 | 0.030 |
Why?
|
| Models, Animal | 1 | 2015 | 464 | 0.030 |
Why?
|
| Checkpoint Kinase 1 | 1 | 2012 | 24 | 0.030 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2012 | 93 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2011 | 170 | 0.020 |
Why?
|
| Ligation | 1 | 2010 | 132 | 0.020 |
Why?
|
| Protein Kinases | 1 | 2012 | 330 | 0.020 |
Why?
|
| Antigens, CD34 | 1 | 2010 | 108 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2012 | 809 | 0.020 |
Why?
|
| Gene Expression | 1 | 2015 | 1566 | 0.020 |
Why?
|
| Hypertension, Pulmonary | 1 | 2014 | 430 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2010 | 324 | 0.020 |
Why?
|
| Clathrin | 1 | 2009 | 24 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2011 | 456 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2010 | 216 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2012 | 644 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2012 | 715 | 0.020 |
Why?
|
| Base Sequence | 1 | 2012 | 3093 | 0.020 |
Why?
|
| Female | 3 | 2023 | 65500 | 0.020 |
Why?
|
| Hypertension | 1 | 2014 | 1287 | 0.020 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 5 | 1 | 2004 | 5 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2009 | 880 | 0.010 |
Why?
|
| Cell Lineage | 1 | 2006 | 340 | 0.010 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2004 | 144 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2004 | 862 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2004 | 523 | 0.010 |
Why?
|